Recall archive / FDA drug enforcement
Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 ... — FDA record D-0261-2023
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Nov 9, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland
- Reason
- CGMP deviations
- Classification
- Class II
- Recalling firm
- DISCOVERY PHARMA LLC
- Quantity
- 21,892 tubes
- Agency-reported status
- Terminated
- Source record identifier
- D-0261-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lots: 22123 Exp. 01/2024; 21732 Exp. 07/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
CA, FL, WA
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Feb 8, 2023
- Recall initiation date
- Nov 9, 2022
- Center classification date
- Feb 1, 2023
- Termination date
- Apr 29, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.